source
- Biologics surge drives CMOs and CDMOs to boost sterile fill-finish and prefilled syringe capacityBiologics, biosimilars and GLP-1 therapies are increasing demand for sterile injectable products, prompting contract manufacturers to expand capacity. CMOs and CDMOs are adding fill-finish, lyophi…
- FDA releases new guidances on adhesive performance and skin irritation studies for transdermal generic drugsThe U.S. Food and Drug Administration has issued two new guidances that address transdermal or topical delivery systems for generic drugs. One is a final guidance that outlines how to assess adhesi…